推动中国老年科学前行:中华医学会老年医学分会首届国际交流论坛纪要
2025年8月17日在广州举行的中华医学会老年医学分会首届国际交流论坛,汇聚国际专家与中国青年研究者,展示衰老研究最新进展。议题涵盖肌肉骨骼衰老、心血管衰老、代谢调控、神经退行性界面和老年综合评估,聚焦新机制与早期风险预测、干预及个体化管理,并强调性别差异和基础发现向临床转化。
要点
- 论坛聚焦肌肉骨骼衰老、心血管衰老、代谢调控、神经退行性变及老年综合评估等衰老研究前沿。
- 重点讨论RNA表观转录组学、线粒体稳态和器官间通讯等新机制及早期风险预测与个体化管理。
- 强调性别差异和基础发现向临床转化,以及多学科、国际协作和数据共享对健康老龄化的必要性。
核心结论
- 论坛强调需通过多学科和国际协作、持续伙伴关系、数据共享与能力建设,加速形成基于证据、可扩展的健康老龄化方案。
研究设计与样本
- 2025年8月17日在广州举行的中华医学会老年医学分会首届国际交流论坛会议纪要,汇聚国际专家与中国青年研究者进行专题报告。
主要发现
- 报告覆盖肌肉骨骼衰老(线粒体功能障碍、肌肉-骨骼通讯、外泌体介导的肌少症与骨质疏松机制)、心血管衰老(酪氨酸激酶抑制剂和蒽环类药物心脏毒性)、代谢调控(肌少性肥胖与肠-肌肉轴)、神经退行性界面(阿尔茨海默病中雄激素介导的单核细胞-小胶质细胞相互作用)和老年综合评估(肌肉特异性力量、内在能力、步态生物标志物)。
- 论坛特别关注RNA表观转录组学、线粒体稳态和器官间通讯等新机制,以及早期风险预测、干预和个体化管理策略。
- 论坛强调应关注性别特异性差异并将基础发现转化为临床应用。
临床怎么用
- 临床可关注肌肉特异性力量、内在能力和步态生物标志物在老年综合评估中的应用。
- 对接受酪氨酸激酶抑制剂或蒽环类药物治疗者,需关注心脏毒性风险。
- 肌少性肥胖与肠-肌肉轴、线粒体功能障碍等机制提示早期风险预测和个体化管理的重要性。
局限性
- 本文为论坛会议纪要,未报告具体研究设计、样本量、效应量或统计阈值。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Held on August 17, 2025 in Guangzhou, the inaugural International Exchange Forum of the Chinese Geriatrics Society marked a significant milestone in advancing geroscience and fostering global collaboration in China. The forum brought together leading international experts and emerging Chinese researchers to present the latest advances in aging research. Presentations covered various topics, such as musculoskeletal aging (mitochondrial dysfunction, muscle-bone communication, and exosome-mediated mechanisms in sarcopenia and osteoporosis), cardiovascular aging (tyrosine kinase inhibitor- and anthracycline-induced cardiotoxicity), metabolic regulation (sarcopenic obesity and the gut-muscle axis), neurodegenerative interfaces (androgen-mediated monocyte-microglia interactions in Alzheimer's disease), and geriatric assessment (muscle-specific strength, intrinsic capacity, and gait biomarkers). There was a particular focus on novel mechanistic insights, such as RNA epitranscriptomics, mitochondrial homeostasis, and inter-organ communication, as well as on strategies for early risk prediction, intervention, and personalized management. The forum also emphasized the importance of addressing sex-specific differences and translating basic discoveries into clinical applications. As a platform designed to promote academic dialogue and collaboration, the forum successfully brought together the Chinese and global geroscience communities. It emphasized the necessity of multidisciplinary and international efforts to address the challenges posed by population aging. Moving forward, sustained partnerships, data sharing, and capacity-building initiatives will be essential to accelerating the development of evidence-based, scalable solutions for healthy aging in China and beyond. This event sets a precedent for future exchanges that integrate scientific innovation with clinical practice to improve the health and quality of life of aging populations worldwide.
引用
- Zhang L, Ji T, Bi J, et al. Moving geroscience forward in China: proceedings of the first international exchange forum of the Chinese Geriatrics Society. J Gerontol A Biol Sci Med Sci. 2026. PMID: 41692982. doi:10.1093/gerona/glag042
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。